SEC Form 4 · accession 0001209191-17-002652
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S. Levine
Officer — SVP,General Counsel & Sec.
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2017 | M | 17,250 | $4.71 | A | 17,250 | D | |
| Common Stock | Jan 4, 2017 | M | 250 | $5.19 | A | 17,500 | D | |
| Common Stock | Jan 4, 2017 | S | 17,500 | $12.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.71 | Jan 4, 2017 | M | 17,250 | D | — | Dec 3, 2025 | Common Stock | 17,250 | 51,750 | D |
| Stock Option (Right to Buy)F3 | $5.19 | Jan 4, 2017 | M | 250 | D | — | Apr 13, 2025 | Common Stock | 250 | 57,274 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
- F2This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
- F3This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.